While drugs may be expensive to develop, in this specific case, it doesn't apply. At all. The drug here is a combination of two drugs that are now both in the generic listing. The combination is based on a study done years ago where they tried out the combo and it didn't work. As it turns out, it does work, but that was only after massging the numbers where it was found it DID work for a small subgroup (which is why there is now a heart drug for blacks as opposed to just a general heart drug).

There is nothing new here at all other than the fact that the two drugs were combined.

Want to make your own Excedrin? Take one aspirin, one tylenol and wash it down with a shot of espresso. Same concept. (I love NPR)

That may be true in this case, however one has to remember that the successful drugs need to pay for the successful research as well as the unsuccessful research.

If you want to do something like regulate prices or reduce patent lengths, the effect of this is to simply reduce the risk drug companies will take on (ie: they will pursue things like this or other things where there may not be a huge payout, but the probabilities of success are very very very high).

RE: Maker of Heart Drug Intended for Blacks Bases Price on Patients' Wealth